Vanta Bioscience Limited (BOM:540729)

Vanta Bioscience Ratios and Metrics

Market cap in millions INR. Fiscal year is April - March.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jan 20, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Market Capitalization	123	140	404	363	693	1,029
Market Cap Growth	-72.14%	-65.44%	11.30%	-47.66%	-32.61%	79.12%
Enterprise Value	427	753	997	816	1,109	1,241
Last Close Price	19.50	22.12	64.00	57.50	109.85	163.00
PE Ratio	-	-	-	-	786.08	228.87
PS Ratio	9.97	7.11	4.16	5.78	6.92	10.24
PB Ratio	0.64	3.69	3.11	1.92	2.36	3.92
P/TBV Ratio	-	-	-	5.25	3.79	4.30
P/OCF Ratio	-	-	15.05	-	13.14	14.76
EV/Sales Ratio	34.61	38.37	10.25	13.01	11.07	12.35
EV/EBITDA Ratio	-	-	75.03	-	29.19	30.93
EV/EBIT Ratio	-	-	-	-	44.66	44.95
Debt / Equity Ratio	1.59	18.52	4.70	3.02	1.53	1.37
Debt / EBITDA Ratio	-	-	45.87	-	11.81	8.97
Asset Turnover	0.02	0.02	0.11	0.08	0.13	0.17
Inventory Turnover	0.20	0.22	0.12	0.14	0.10	0.08
Quick Ratio	0.14	0.26	0.33	0.12	0.36	0.55
Current Ratio	0.80	0.58	0.75	0.86	1.01	1.34
Return on Equity (ROE)	-76.80%	-158.62%	-53.95%	-43.27%	0.48%	1.77%
Return on Assets (ROA)	-6.65%	-6.33%	-2.33%	-3.81%	2.05%	2.92%
Return on Invested Capital (ROIC)	-15.27%	-11.77%	-4.23%	-6.75%	2.19%	4.15%
Return on Capital Employed (ROCE)	-17.70%	-14.60%	-5.10%	-7.60%	3.70%	5.00%
Earnings Yield	-36.76%	-34.20%	-5.73%	-17.86%	0.13%	0.44%
FCF Yield	-73.89%	-65.19%	-1.78%	-80.77%	-17.16%	-14.79%
Buyback Yield / Dilution	-6.35%	-	-	-	-	-

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.